CD30 Ligand/CD30 Interaction Is Involved in Pathogenesis of Inflammatory Bowel Disease

被引：0
|
作者：
Shinichi Somada
Hiromi Muta
Kazuhiko Nakamura
Xun Sun
Kuniomi Honda
Eikichi Ihara
Hirotada Akiho
Ryoichi Takayanagi
Yasunobu Yoshikai
Eckhard R. Podack
Kenzaburo Tani
机构：
[1] Kyushu University Hospital,Department of Advanced Molecular and Cell Therapy
[2] Kyushu University,Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences
[3] Kyushu University,Division of Host Defense, Research Center For Prevention of Infectious Diseases, Medical Institute of Bioregulation
[4] Kyushu University,Research Center for Advanced Immunology
[5] China Medical University,Institute of Immunology
[6] University of Miami,Department of Microbiology and Immunology, Miller School of Medicine
来源：
Digestive Diseases and Sciences | 2012年 / 57卷
关键词：
CD30; CD30 ligand; Inflammatory bowel disease; Ulcerative colitis; Crohn’s disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2031 / 2037
页数：6
相关论文
共 50 条
  • [41] Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30
    Hargreaves, PG
    Al-Shamkhani, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (01) : 163 - 173
  • [42] CD30 LIGAND - PLEIOTROPIC EFFECTS FOR THE GROWTH-CONTROL OF CD30+ LYMPHOMAS
    GRUSS, HJ
    WILLIAMS, DE
    DOWER, SK
    BLOOD, 1994, 84 (10) : A160 - A160
  • [43] Role of CD30/CD30L interactions in autoimmune disease.
    Barone, D
    Kennedy, M
    Sivakumar, PV
    Brown, S
    Mohler, K
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S85 - S85
  • [44] Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases
    Ruggeri, RM
    Barresi, G
    Sciacchitano, S
    Trimarchi, F
    Benvenga, S
    Trovato, M
    HISTOLOGY AND HISTOPATHOLOGY, 2006, 21 (03) : 249 - 256
  • [45] Proliferation of CD30+ T-Helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand
    Willers, J
    Dummer, R
    Kempf, W
    Kündig, T
    Burg, G
    Kadin, ME
    CLINICAL CANCER RESEARCH, 2003, 9 (07) : 2744 - 2754
  • [46] Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease
    Amedei, Amedeo
    Pimpinelli, Nicola
    Grassi, Alessia
    Della Bella, Chiara
    Niccolai, Elena
    Brancati, Simona
    Benagiano, Marisa
    D'Elios, Sofia
    Bosi, Alberto
    D'Elios, Mario M.
    AUTOIMMUNITY HIGHLIGHTS, 2014, 5 (01) : 21 - 26
  • [47] The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice
    Fuchiwaki, Takafumi
    Sun, Xun
    Fujimura, Kenjiro
    Yamada, Hisakata
    Shibata, Kensuke
    Muta, Hiromi
    Podack, Eckhard R.
    Kawauchi, Hideyuki
    Yoshikai, Yasunobu
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (10) : 2947 - 2954
  • [48] CD30 expression in bladder cancer
    Cooke, PW
    James, ND
    Ganesan, R
    Wallace, M
    Burton, A
    Young, LS
    JOURNAL OF PATHOLOGY, 1999, 188 (01): : 38 - 43
  • [49] Expression of CD30 in celiac sprue
    Molina, Enrique
    Feldman, Paul
    Vincentelli, Cristina
    Martinez, Antonio
    Barkin, Jamie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S102 - S102
  • [50] Soluble CD30 serum antigen in Kawasaki disease
    Vagliasindi, C
    Spinozzi, F
    Sensi, L
    Radicioni, M
    DeRosa, O
    Solinas, L
    Vaccaro, R
    Bertotto, A
    ACTA PAEDIATRICA, 1997, 86 (03) : 317 - 318
12345